Delivery Order SPE2DB22D2103-SPE2DB23FR9RY
Award Date 9/21/23
Potential Completion Date 10/13/23
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,941.36 delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60-count package) on September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price, competitively awarded contract (non-set-aside) will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency Troop Support Medical awarded a $1,251 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 60 capsules of the 42 mg dosage of INBRIJA, an inhalation medication used to treat Parkinson's disease symptoms. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 21, 2023 through August 11, 2023. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60 count) valued at $1,941.36 under a firm fixed price contract type. This award, issued on July 24, 2025, represents a non-competitive, non-set-aside transaction with an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for INBRIJA 42 mg inhalation capsules (60-count units) under a firm fixed-price contract with a ceiling value of $1,879.50. This is a non-set-aside competitive award with an ultimate completion date of January 22, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at one thousand two hundred fifty-one dollars by the Defense Logistics Agency Troop Support Medical to provide sixty capsules of the 42 mg dosage of INBRIJA, an inhalation medication used to treat Parkinson's disease symptoms. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three week period concluding in...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,941.36 for INBRIJA 42 mg inhalation capsules (60-count) by the Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense. The contract, awarded on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a firm fixed-price, competitively awarded procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate headquarters in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,941.36 delivery order contract is for the provision of Inbrija 42 mg inhalation capsules, a medication used in the treatment of Parkinson's disease. The contract is a firm fixed-price delivery order with a performance period that extends through May 2025. AmerisourceBergen, which is headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $1,941.36 delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 mg Inhalation Capsules (60-count) on August 25, 2025, with completion scheduled for September 16, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The award was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Inbrija 42 mg inhalation capsules (60-count package) under a firm fixed-price contract with a ceiling value of $1,879.50. This competitive award, with no set-aside designation, utilizes the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026....
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $625.50 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 60 packages of the 42 mg Inbrija inhalation capsules. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 19, 2023 through August 9, 2023. No subcontractors or set aside designations were identified. This delivery order was...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB23FR9RYDelivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,876.50 to Amerisourcebergen Drug Corporation for the supply of 60 packages containing 42 mg capsules of INBRIJA, an inhalation drug used to treat Parkinson's disease symptoms. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning late September through mid-October of 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor supporting the Department of Defense's medical supply needs. No set aside designation or involvement of major subcontractors was indicated in the award information.
Generated 12/21/23, 9:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/21/23 |